trending Market Intelligence /marketintelligence/en/news-insights/trending/mmOcxHoJv2LLTJU1CGRDbA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

NanoString plans common stock offering to raise working capital

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

NanoString plans common stock offering to raise working capital

NanoString Technologies Inc. plans to offer 4.5 million shares in an underwritten public offering.

Seattle-based NanoString will sell 2.5 million common shares, while private equity firm Clarus Lifesciences II LP, a NanoString stockholder, will sell 2 million shares. NanoString will not receive proceeds from the sale by Cambridge, Mass.-based Clarus.

Underwriters will have an option to buy up to 675,000 additional common shares.

NanoString plans to use net proceeds for working capital and general corporate purposes.

J.P. Morgan, UBS Investment Bank and Cowen are acting as joint book-running managers, with Baird acting as lead manager for the offering.

NanoString Technologies is a provider of life science tools for translational research and molecular diagnostic products.